NICE Affirms Guidance Denying Coverage Of Sequential TNF Inhibitors In RA
This article was originally published in The Pink Sheet Daily
Executive Summary
Makers of Humira, Enbrel and Remicade had appealed a negative 2006 appraisal, prompting a second look by UK health care agency.